ArticleEpilepsia2017

Preclinical evaluation of intravenous NAX 810-2, a novel GalR2-preferring analog, for anticonvulsant efficacy and pharmacokinetics.

Cameron S Metcalf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.